GILD Stock Quote
Company Report
Gilead Sciences, Inc. is a pioneering biopharmaceutical company dedicated to discovering, developing, and commercializing medicines that address significant unmet medical needs worldwide. Based in Foster City, California, Gilead operates extensively across the United States, Europe, and other international markets. The company's diverse portfolio includes a range of groundbreaking treatments across multiple therapeutic areas.
Specializing in HIV/AIDS, Gilead offers a suite of products including Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla, which have transformed treatment paradigms for patients living with HIV/AIDS. In response to global health challenges, Gilead developed Veklury, an intravenous injection for the treatment of COVID-19, showcasing its commitment to addressing urgent medical crises.
Beyond infectious diseases, Gilead focuses on advancing therapies for liver diseases with products like Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. The company also leads in hematology, oncology, and cell therapy with innovative treatments such as Yescarta, Tecartus, Trodelvy, and Zydelig. With extensive collaboration agreements with industry leaders and ongoing research initiatives, Gilead Sciences remains at the forefront of medical innovation, continually striving to improve patient outcomes and enhance global healthcare standards.
GILD EPS Chart
GILD Revenue Chart